Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs
Yuta Suzuki, Hiroshi Ishihara
Drug Metabolism and Pharmacokinetics (2021) Vol. 41, pp. 100424-100424
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance
Mingze Xu, Yuming Qi, G.H. Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 20825-20849
Closed Access | Times Cited: 174
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 87
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs
Hideo Takakusa, Norihiko Iwazaki, Makiya Nishikawa, et al.
Nucleic Acid Therapeutics (2023) Vol. 33, Iss. 2, pp. 83-94
Open Access | Times Cited: 53
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients
Arne Matteo Jörgensen, Richard Wibel, Andreas Bernkop‐Schnürch
Small (2023) Vol. 19, Iss. 17
Open Access | Times Cited: 52
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 52
Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid‐Nanoparticle Components for Therapeutic and Vaccine Applications
Kieu Lam, Ada Leung, Alan Martin, et al.
Advanced Materials (2023), pp. 2209624-2209624
Open Access | Times Cited: 51
Evolution of nanomedicine formulations for targeted delivery and controlled release
Sanyogitta Puri, Mariarosa Mazza, Gourgopal Roy, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114962-114962
Closed Access | Times Cited: 41
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
Yelee Kim, Jiwoong Choi, Eun Hye Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 17
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
Maryam Taghdiri, Claudio Mussolino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7333-7333
Open Access | Times Cited: 17
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
Matthew N. O’Brien, David A. Foley, Roger H. Pak, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1
The roles of polymers in mRNA delivery
Pei Huang, Hongzhang Deng, Yongfeng Zhou, et al.
Matter (2022) Vol. 5, Iss. 6, pp. 1670-1699
Open Access | Times Cited: 62
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
Lei Yang, Liming Gong, Ping Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2682-2682
Open Access | Times Cited: 62
Associations between vaccination and quality of life among Taiwan general population: A comparison between COVID-19 vaccines and flu vaccines
Chung‐Ying Lin, Chia-Wei Fan, Daniel Kwasi Ahorsu, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 55
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Hezhi Wang, Qin Lu, Xin Zhang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 970-993
Open Access | Times Cited: 45
Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates
Yuta Suzuki, Takayuki Miyazaki, Hiroki Muto, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 30, pp. 226-240
Open Access | Times Cited: 42
The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis
Wujun Chen, Jiazhen Xu, Yudong Wu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 9, pp. 2879-2896
Open Access | Times Cited: 34
Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices
Masatoshi Maeki, Yuto Okada, Shuya Uno, et al.
Applied Materials Today (2023) Vol. 31, pp. 101754-101754
Open Access | Times Cited: 32
Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
Tiantian Tan, Yuxin Feng, Weimin Wang, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
Rahul G Ingle, Wei‐Jie Fang
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 29
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury
Lauren E. Waggoner, Katelyn Miyasaki, Ester J. Kwon
Biomaterials Science (2023) Vol. 11, Iss. 12, pp. 4238-4253
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top